Cleared Traditional

K240314 - MULA (K2-A1) (FDA 510(k) Clearance)

Class II General & Plastic Surgery device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K240314 · Guangzhou Ciellulu Photoelectric Technology Co., Ltd. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2024
Decision
201d
Days
Class 2
Risk

K240314 is an FDA 510(k) clearance for the MULA (K2-A1). Classified as Powered Light Based Non-laser Surgical Instrument With Thermal Effect (product code ONF), Class II - Special Controls.

Submitted by Guangzhou Ciellulu Photoelectric Technology Co., Ltd. (Guangzhou, CN). The FDA issued a Cleared decision on August 21, 2024 after a review of 201 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4810 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Guangzhou Ciellulu Photoelectric Technology Co., Ltd. devices

Submission Details

510(k) Number K240314 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 02, 2024
Decision Date August 21, 2024
Days to Decision 201 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
87d slower than avg
Panel avg: 114d · This submission: 201d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code ONF Powered Light Based Non-laser Surgical Instrument With Thermal Effect
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4810
Definition A Light Based Non-laser Device That Provides Thermal Effect Including Broad Spectrum Source Devices Such As Intense Pulse Light (ipl). Typically, Indicated To Be Used In Medical Specialties Of General And Plastic Surgery And Of Dermatology/aesthetic. Indication For Use Can Be General And/or Specific.the Classification Regulation 21 Cfr 878.4810 Describes A Device That Is Carbon Dioxide Or Argon Laser Intended To Cut, Destroy, Or Remove Tissue By The Light.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Consultant

Feiying Drug & Medical Consulting Technical Service Group
Riley Chen

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - ONF Powered Light Based Non-laser Surgical Instrument With Thermal Effect

All 72
Devices cleared under the same product code (ONF) and FDA review panel - the closest regulatory comparables to K240314.
Intense Pulsed Light Therapy Device (MMABM-1)
K251545 · Micowey Medical Equipment (Guangxi) Co., Ltd. · Sep 2025
MEDILIGHT
K231952 · Medicreations, LLC · Sep 2025
IPL Treatment Device (MDSQMC-01)
K243123 · Medusa (Guangxi)Medical Devices Co., Ltd. · Jul 2025
DEKA LOTUS
K250281 · El.En S.P.A. · Feb 2025
Intense Pulsed Light Treatment System (LK-PT)
K242440 · Nanjing Bestview Laser S&T Co., Ltd. · Nov 2024
Intense Pulsed Light System (ST-690)
K240482 · Smedtrum Medical Technology Co., Ltd. · May 2024